Evidence map›Paper›PMID 27606290›Full record

ReviewSouth Asian journal of cancer

Lung cancer in the Indian subcontinent.

Vanita Noronha, Rakesh Pinninti, Vijay M Patil, Amit Joshi, Kumar Prabhash

Abstract readReview
In one paragraph

Review in South Asian journal of cancer. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Role of Nanoformulations in the Treatment of Lung Cancer.Recent patents on nanotechnology · 2025
    Review
  8. Review
  9. Uniqueness of lung cancer in Southeast Asia.The Lancet regional health. Southeast Asia · 2024
    Review
  10. Article
  11. Carcinoma lung with cutaneous metastasis: experience from an Indian institute.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2024
    Article
  12. Article
  13. Lung Cancer Survival in Sri Lanka.South Asian journal of cancer · 2023
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vanita NoronhaDepartment of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Rakesh PinnintiDepartment of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Vijay M PatilDepartment of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Amit JoshiDepartment of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Kumar PrabhashDepartment of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Smoking tobacco, both cigarettes and beedis, is the principal risk factor for causation of lung cancer in Indian men; however, among Indian women, the association with smoking is not strong, suggesting that there could be other risk factors besides smoking. Despite numerous advances in recent years in terms of diagnostic methods, molecular changes, and therapeutic interventions, the outcomes of the lung cancer patients remain poor; hence, a better understanding of the risk factors may impact the preventive measures to be implemented at the community level. There is a lack of comprehensive data on lung cancer in India. In this review, we attempt to collate the available data on lung cancer from India.

Indexed as

EpidemiologyIndialung cancernonsmokers

Identifiers

PMID27606290
PMCPMC4991146

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.